A physiologically-based recirculatory meta-model for nasal fentanyl in man

Area of Science:

• Pharmacology
• Physiology
• Biomathematics

Background:

• Pharmacokinetic (PK) and pharmacodynamic (PD) data from fentanyl nasal delivery systems require integrated analysis.
• Understanding fentanyl's kinetics in arterial blood, lung, and brain is crucial for effective pain management.

Purpose of the Study:

• To reconcile existing PK/PD data using a physiologically-based population recirculatory model.
• To develop a meta-model for fentanyl that accounts for arterial/venous concentrations, central nervous system (CNS) effects, and influences of body size and age.

Main Methods:

• Developed organ-specific sub-models for fentanyl kinetics (brain, lung, muscle) using concentration gradients.
• Integrated sub-models into a "whole body" recirculatory model with compartments for venous mixing, liver, gut, kidney, and other tissues.
• Incorporated inter-individual variability through allometric scaling, age/weight effects on cardiac output, and variations in plasma free fraction and hepatic extraction.

Main Results:

• The model successfully integrated diverse fentanyl PK/PD data, including arterial and venous concentrations.
• Post-operative pain scores demonstrated a temporal relationship with predicted fentanyl concentrations in the brain.
• The model provided a mechanistic interpretation of fentanyl disposition.

Conclusions:

• A physiologically-based meta-modelling approach effectively describes clinical PK-PD studies of fentanyl.
• This approach offers a mechanistic understanding of fentanyl's disposition and its relationship to clinical effects.
• The developed model can account for patient variability in fentanyl kinetics and response.